Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Siegfried Holding AG ( (CH:SFZN) ) is now available.
Siegfried Holding AG has announced a transition in its Chief Financial Officer position, with Tania Micki set to succeed Reto Suter on July 1, 2026. This change is part of a long-term succession plan, with Micki bringing over 20 years of experience in finance leadership roles from various international companies. The transition is expected to support Siegfried’s continued growth and strategic focus, with Micki’s expertise seen as instrumental in delivering long-term value for shareholders.
The most recent analyst rating on (CH:SFZN) stock is a Hold with a CHF80.00 price target. To see the full list of analyst forecasts on Siegfried Holding AG stock, see the CH:SFZN Stock Forecast page.
More about Siegfried Holding AG
Siegfried Holding AG is a global life sciences company that operates as a Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry. It is involved in manufacturing pharmaceutical APIs and drug products, including tablets, capsules, sterile vials, ampoules, cartridges, and ointments, while also providing development services. The company is publicly listed on the SIX Swiss Exchange and operates across multiple continents with significant sales and a large workforce.
YTD Price Performance: -23.61%
Average Trading Volume: 72,566
Technical Sentiment Signal: Sell
Current Market Cap: CHF3.38B
See more data about SFZN stock on TipRanks’ Stock Analysis page.